Kevin has been associated with the biomedical industry for nearly twenty years, including receipt of competitive grant awards at the undergraduate, graduate, and post-graduate levels as well as a research fellowship at Yale University.
Prior to enjoining with the CMEI family of corporations as Chief Medical Officer and Strategic and Innovation Officer, Kevin served as Chief Medical Officer of an in vitro diagnostic medical device company as well as VP of Medical Affairs for an exchange-listed global pharmaceutical corporation, where he engaged with over eighty clinical trial sites worldwide for Phase ii and iii clinical studies for treating glioblastoma multiforme and other aggressive solid tumors. He also developed new clinical protocols and forged collaborations with universities and larger multinational pharma concerns. In addition, Dr. Lye is a co-founder of Telomax Biotech, Inc., a corporation dedicated to developing products designed to inhibit and reverse intracellular aging; he also co-founded EDWO, LLC, a partnership focusing on dental improvement technologies.
Prior to the above, Kevin was VP and Chief Medical Officer of another technology-holding company, and led its pharmaceutical subsidiary through an evaluation of its intellectual property covering two pipeline molecules. Working concomitantly with another subsidiary, Dr. Lye designed algorithms to identify high-risk patients from aggregated patient claims data provided by healthcare insurers. Kevin also spent over five years in the world of biomedical device development as the director of clinical research for a cellular technology company, helping bring a stem cell isolation robot to defined markets and authoring first-in-man clinical trial protocols in orthopædic surgery, vascular surgery, cardiac surgery, plastic surgery, and other venues. Preceding this was ten years of experience in post-graduate training.
Dr. Lye brings expertise to clients from experiences with these and other biomedical and healthcare groups, ranging in size from from startup to multinational; he has authored or co-authored over 25 publications on topics including novel therapies, wound closure devices, stem cells, and gene transfer.
Interacting with FDA and USPTO, managing intellectual property registrations, coordinating contract research organizations, and securing business development transactions are examples of how he has increased the value of groups with whom he has served.
Kevin is privileged to have worked in the laboratories of and been mentored by luminaries such as James D. Otvos, phd, founder of LipoMed, Inc.; Louis Argenta, md, inventor of negative-pressure wound therapy devices used worldwide to heal complex wounds; and Irvin M. Modlin, md, phd, a widely renowned innovator and director of the Gastric Pathobiology Research Group at Yale. Dr. Lye has been an invited speaker to multiple international conferences, and over 60 presentations relating to his research projects and corporate properties have been made around the world in various venues. Kevin earned his md degree from the Wake Forest University School of Medicine and his mba from Hawaii Pacific University with highest distinction. In addition to serving as an assistant professor at the John A. Burns School of Medicine of the University of Hawaii, Dr. Lye serves on the board of directors of the Association of Owners of Kukui Plaza, the largest condominium project in the state of Hawaii, with a property valuation exceeding $275 million. He also serves as an emeritus member of the board of Adult Friends for Youth, a Honolulu-based organization renowned for interrupting the gang-life cycle that can befall at-risk children on the island of O‘ahu and elsewhere; he is a past co-treasurer of the Hawaii chapter of SAG-AFTRA. Dr. Lye is an elected official serving on the Downtown–Chinatown Neighborhood Board of the City and County of Honolulu.
Industries
Science
Medicine and healthcare
Technology
Functions
Non-dilutive funding source identification
Military/DOD asset acquisition
Quality Management system implementation
Medical affairs
Clinical and preclinical research
Statistical analyses
Medical device development
FDA and EMA regulatory processes
Creative problem solving
Business plan development
Document editing
Ray Tsuchiyama is a consultant based in Honolulu, Hawaii. In the 1980s he was at Digital Equipment Corporation at its Massachusetts headquarters, then returned to Honolulu to join Castle & Cooke and Mitsui Real Estate; he launched The Hawaii High Tech Journal magazine.
From 1991- 2011 he lived in Tokyo and had roles with the Massachusetts Institute of Technology, Analog Devices, and start-up Tegic Communications, which grew from zero to $100 million annual revenues over six years. After AOL Time Warner acquired Tegic, he led Asia-Pacific and Latin American operations. His team’s activities for consumer usage marketing programs was honored at the Mobile World Congress in Barcelona, Spain — winning the GSMA Global Mobile Award for Best Use of Mobile for Social and Economic Development.
He was senior consultant to Google, Inc. in product management leadership. Relocating to Hawaii after the 2011 East Japan Earthquake, he was with University of Hawaii Foundation on Maui, and was appointed COO of the DHS/FEMA-funded National Disaster Preparedness Training Center. He has lectured on disaster management at the Asia-Pacific Center for Security Studies.
He has a BA degree from Western Washington University and a MFA degree from University of Massachusetts at Amherst, and is a Farrington High School alum, where he is launching a new project. He was on the President’s International Advisory Committee at Barnard College (Columbia University), a former Maui County Commissioner, and currently serves on the board of the Pacific and Asian Affairs Council. He was formerly on the board of the Hawaii District Export Council.
He was a co-host for a show on China for ThinkTech Hawaii and co-hosts the series “Life after Statehood”. He contributes to Civil Beat, Honolulu Star-Advertiser, The Hawaiian Journal of History and was a blogger for the Maui News, winning three consecutive annual awards from the Society of Professional Journalists. His essay on C. W. Dickey won the AIA/Hawaii Chapter prize for “best essay on Hawaii regional architecture”. He has also published in Forbes.com; Honolulu; The Hindu; Mobile Communications; Japan Times; Asia Times; Asian Business; New York Times; Reuters; Nikkei Weekly. Quoted in: Newsweek, Financial Times, BusinessWeek, China Daily, Toyo Keizai, San Jose Mercury, and Science.
He was an invited speaker at the University of Southern California “Doing Business in Japan” program, U.S.-Asia Technology Management Program (Stanford University) on “Developing Asia-Wide Technology Perspectives”, plus seminars for the U.S. Embassy (Japan), Tokyo Institute of Technology, Waseda MBA program, and University of California at Berkeley.
In 2017 he was appointed Co-Chairperson (representing Izumo Taishakyo Shinto Shrine) for the annual Hiroshima Peace Bell Ringing Ceremony, part of an ecumenical community alliance, including the Hawaii YMCA and Hiroshima State/City-Sister associations. He was the recipient of the East-West Center “Honor Award” for contributions to “Asia-Pacific relations”.
Iqbal is a general management professional with a background in finance and accounting, project management and process transformation. His deep interests are in partnering with,
- business managers to imagine and execute solutions for complex problems by leveraging internal and external expertise
- visionary small business leaders to put all the organizational pieces together for a higher level of
performance needed to grow faster
Iqbal is the co-founder of GUILD (an affiliate of GUILD Consulting) that provides specialized expertise to businesses via www.guild.im. In his past, he managed ProAccounting Hawaii an outsourced accounting firm based in Hawaii. Prior to that he held various management roles at General Electric in areas of finance, process reengineering and technology.
Originally from India, Iqbal has a bachelors degree in Chemical Engineering and an MBA from leading institutions there.
